Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 6
2005 6
2006 2
2007 6
2008 2
2009 1
2010 5
2011 9
2012 9
2013 3
2014 2
2015 5
2016 9
2017 7
2018 8
2019 5
2020 6
2021 7
2022 7
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy.
Wang M, Yao LC, Cheng M, Cai D, Martinek J, Pan CX, Shi W, Ma AH, De Vere White RW, Airhart S, Liu ET, Banchereau J, Brehm MA, Greiner DL, Shultz LD, Palucka K, Keck JG. Wang M, et al. Among authors: pan cx. FASEB J. 2018 Mar;32(3):1537-1549. doi: 10.1096/fj.201700740R. Epub 2018 Jan 3. FASEB J. 2018. PMID: 29146734 Free PMC article.
Preclinical Models for Bladder Cancer Research.
Zhu S, Zhu Z, Ma AH, Sonpavde GP, Cheng F, Pan CX. Zhu S, et al. Among authors: pan cx. Hematol Oncol Clin North Am. 2021 Jun;35(3):613-632. doi: 10.1016/j.hoc.2021.02.007. Epub 2021 Apr 16. Hematol Oncol Clin North Am. 2021. PMID: 33958154 Free PMC article. Review.
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors.
Rehman H, Chandrashekar DS, Balabhadrapatruni C, Nepal S, Balasubramanya SAH, Shelton AK, Skinner KR, Ma AH, Rao T, Agarwal S, Eich ML, Robinson AD, Naik G, Manne U, Netto GJ, Miller CR, Pan CX, Sonpavde G, Varambally S, Ferguson JE 3rd. Rehman H, et al. Among authors: pan cx. JCI Insight. 2022 Aug 22;7(16):e155899. doi: 10.1172/jci.insight.155899. JCI Insight. 2022. PMID: 35852858 Free PMC article.
Insights on recent innovations in bladder cancer immunotherapy.
Abd El-Salam MA, Smith CEP, Pan CX. Abd El-Salam MA, et al. Among authors: pan cx. Cancer Cytopathol. 2022 Sep;130(9):667-683. doi: 10.1002/cncy.22603. Epub 2022 Jun 2. Cancer Cytopathol. 2022. PMID: 35653623 Free article. Review.
Contemporary management of muscle-invasive bladder cancer.
Dall'Era MA, Cheng L, Pan CX. Dall'Era MA, et al. Among authors: pan cx. Expert Rev Anticancer Ther. 2012 Jul;12(7):941-50. doi: 10.1586/era.12.60. Expert Rev Anticancer Ther. 2012. PMID: 22845409 Free PMC article. Review.
103 results